The transcript levels of SPRR1A in pancreatic cancers were elevated in 89 of 177 cases and were significantly higher than in normal pancreatic tissues (mean TPM 1.28 vs. 45.99, p < 0.0001) (Fig 1A). This evidence concerns the gene SPRR1A and pancreatic neoplasm.